Human papillomavirus vaccination uptake and determinant factors among adolescent schoolgirls in sub-Saharan Africa : A systematic review and meta-analysis
Despite the ongoing global vaccination campaign aimed at preventing human papillomavirus (HPV) related health issues, the uptake of the HPV vaccine remains unacceptably low in developing regions, particularly in sub-Saharan Africa (SSA). Therefore, this systematic review and meta-analysis aimed at determining the pooled prevalence and associated factors of HPV vaccine uptake among adolescent school girls in SSA. Electronic bio-medical databases were explored. Pooled prevalence, publication bias, meta-regression, sub-group, and sensitivity analysis were performed. The estimated pooled prevalence of HPV vaccine uptake was 28.53% [95% CI: (5.25, 51.81)]. Having good knowledge and a positive attitude was significantly associated with HPV vaccine uptake in SSA. Subgroup analysis revealed the highest uptake was 62.52% from Kenya and the lowest was 3.77% in Nigeria. The HPV vaccine uptake is low. It underscores the need for community education, school-based immunization, and education programs that promote the uptake of the vaccine to increase coverage.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
|---|---|
| Enthalten in: |
Human vaccines & immunotherapeutics - 20(2024), 1 vom: 31. März, Seite 2326295 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Asgedom, Yordanos Sisay [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Adolescent |
|---|
| Anmerkungen: |
Date Completed 21.03.2024 Date Revised 23.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1080/21645515.2024.2326295 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369955609 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369955609 | ||
| 003 | DE-627 | ||
| 005 | 20240323235444.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240320s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/21645515.2024.2326295 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1342.xml |
| 035 | |a (DE-627)NLM369955609 | ||
| 035 | |a (NLM)38505959 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Asgedom, Yordanos Sisay |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Human papillomavirus vaccination uptake and determinant factors among adolescent schoolgirls in sub-Saharan Africa |b A systematic review and meta-analysis |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 21.03.2024 | ||
| 500 | |a Date Revised 23.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Despite the ongoing global vaccination campaign aimed at preventing human papillomavirus (HPV) related health issues, the uptake of the HPV vaccine remains unacceptably low in developing regions, particularly in sub-Saharan Africa (SSA). Therefore, this systematic review and meta-analysis aimed at determining the pooled prevalence and associated factors of HPV vaccine uptake among adolescent school girls in SSA. Electronic bio-medical databases were explored. Pooled prevalence, publication bias, meta-regression, sub-group, and sensitivity analysis were performed. The estimated pooled prevalence of HPV vaccine uptake was 28.53% [95% CI: (5.25, 51.81)]. Having good knowledge and a positive attitude was significantly associated with HPV vaccine uptake in SSA. Subgroup analysis revealed the highest uptake was 62.52% from Kenya and the lowest was 3.77% in Nigeria. The HPV vaccine uptake is low. It underscores the need for community education, school-based immunization, and education programs that promote the uptake of the vaccine to increase coverage | ||
| 650 | 4 | |a Meta-Analysis | |
| 650 | 4 | |a Systematic Review | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Uptake | |
| 650 | 4 | |a adolescent | |
| 650 | 4 | |a human papilloma virus vaccine | |
| 650 | 4 | |a meta-analysis | |
| 650 | 4 | |a sub-Saharan Africa | |
| 650 | 4 | |a systematic review | |
| 650 | 7 | |a Papillomavirus Vaccines |2 NLM | |
| 700 | 1 | |a Kebede, Tsegaye Melaku |e verfasserin |4 aut | |
| 700 | 1 | |a Seifu, Beminate Lemma |e verfasserin |4 aut | |
| 700 | 1 | |a Mare, Kusse Urmale |e verfasserin |4 aut | |
| 700 | 1 | |a Asmare, Zufan Alamrie |e verfasserin |4 aut | |
| 700 | 1 | |a Asebe, Hiwot Altaye |e verfasserin |4 aut | |
| 700 | 1 | |a Kase, Bizunesh Fantahun |e verfasserin |4 aut | |
| 700 | 1 | |a Shibeshi, Abdu Hailu |e verfasserin |4 aut | |
| 700 | 1 | |a Tebeje, Tsion Mulat |e verfasserin |4 aut | |
| 700 | 1 | |a Sabo, Kebede Gemeda |e verfasserin |4 aut | |
| 700 | 1 | |a Fente, Bezawit Melak |e verfasserin |4 aut | |
| 700 | 1 | |a Lombebo, Afework Alemu |e verfasserin |4 aut | |
| 700 | 1 | |a Koyira, Mengistu Meskele |e verfasserin |4 aut | |
| 700 | 1 | |a Kassie, Gizachew Ambaw |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Human vaccines & immunotherapeutics |d 2012 |g 20(2024), 1 vom: 31. März, Seite 2326295 |w (DE-627)NLM21576823X |x 2164-554X |7 nnns |
| 773 | 1 | 8 | |g volume:20 |g year:2024 |g number:1 |g day:31 |g month:03 |g pages:2326295 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/21645515.2024.2326295 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 20 |j 2024 |e 1 |b 31 |c 03 |h 2326295 | ||